NASDAQ:SNTA   SYNTA PHARMACEUTICALS CORP
8 0 0
The market isn't seeing SNTA's true potential. This stock is deeply undervalued at the moment. A true price range it should trade at would be $1.10 - $ 1.75 in the medium term even without any effects of expected positive news. SNTA's merger with Madrigal Pharma             is also being discounted, while in actual fact it's a great combination, the management details would stand testament to that.
United States
United Kingdom
India
España
France
Italia
Polska
Brasil
Россия
Türkiye
Indonesia
Malaysia
日本
한국
Home Stock Screener Forex Signal Finder Economic Calendar How It Works Chart Features House Rules Moderators For the WEB Widgets Stock Charting Library Priority Support Feature Request Blog & News FAQ Help & Wiki Twitter
Profile Profile Settings Account and Billing Priority Support Ideas Published Followers Following Private Messages Chat Sign Out